Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)

China · Delayed Price · Currency is CNY

4.730

-0.010 (-0.21%)

Jun 18, 2026, 3:00 PM CST

-27.34% (1Y)

Market Cap	2.43B -25.8%
Revenue (ttm)	1.90B -3.0%
Net Income	36.13M -42.1%
EPS	0.06 -47.9%
Shares Out	534.07M
PE Ratio	76.40
Forward PE	n/a
Dividend	0.07 (1.43%)
Ex-Dividend Date	Jun 17, 2026

Volume	4,101,480
Open	4.740
Previous Close	4.740
Day's Range	4.670 - 4.800
52-Week Range	4.700 - 7.530
Beta	0.40
Analysts	Strong Buy
Price Target	18.00 (+280.55%)
Earnings Date	Aug 28, 2026

About SHA:600613

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, tonic and sedative, cold and cough, anti-fungal, gynecology, and other treatment fields. Its products include prescription drugs and OTC products, including products include sodium cantharidate vitamin B6 injection, sodium cantharidin i... [Read more]

Industry Drug Manufacturers - General

Sector Healthcare

Founded 1990

Employees 1,196

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600613

Full Company Profile

Financial Performance

In 2025, SHA:600613's revenue was 1.95 billion, a decrease of -4.71% compared to the previous year's 2.05 billion. Earnings were 38.24 million, a decrease of -46.43%.

Financial Statements